“Effects of inhibition of lymphangiogenesis by the vascular endothelial growth factor receptor 3 (VEGFR-3) inhibitor, MAZ51 on full thickness wounds in mice”, Veins & Lymphatics, vol. 10, no. 1, Mar. 2021, doi: 10.4081/vl.2021.9385.